02
HLB Inc
028300.KQ·KOSDAQSeoul KRFounded 2001100 employees
Small CapbiotechPublicOncology
Platform: Rivoceranib VEGFR
Market Cap
$0.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (028300.KQ)
Loading 028300.KQ stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Motaderotide | 028-4572 | Phase 2 | 2 | C5 | PAHMDS | ||
| 028-9914 | 028-9914 | NDA/BLA | 1 | CGRP | CeliacPBC |
SEC Filings & Financial Documents
SEC filings are not available for KOSDAQ-listed companies.
HLB Inc trades on KOSDAQ (KR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)